ZATA PHARMACEUTICALS, INC. SBIR Phase I Award, March 2019
A SBIR Phase I contract was awarded to Zata Pharmaceuticals in March, 2019 for $780,492.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Name
# Contributions
Last Contribution
Find more entities like ZATA PHARMACEUTICALS, INC. SBIR Phase I Award, March 2019
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.